Spyre Therapeutics, Inc. (SYRE)

CIK 1636282 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Spyre Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 8, 20268-K0001636282-26-000113
Sep 3, 202640001636282-26-000111
Sep 3, 202640001636282-26-000107
Sep 3, 202640001636282-26-000109
Sep 1, 20261440001950047-26-008970
Aug 25, 20268-K0001636282-26-000105
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352655
Aug 14, 2026SCHEDULE 13G/A0001493215-26-000157
Aug 10, 202640001636282-26-000102
Aug 7, 20261440001950047-26-007819
Aug 7, 20261440001950047-26-007821
Aug 5, 202640001636282-26-000099
Aug 5, 202640001636282-26-000100
Aug 4, 20268-K0001636282-26-000098
Aug 4, 202610-Q0001636282-26-000096
Aug 3, 20261440001950047-26-007571
Jul 2, 202640001636282-26-000086
Jul 2, 202640001636282-26-000088
Jul 2, 202640001636282-26-000087
Jul 1, 20261440001950047-26-006779
Jun 26, 2026S-3ASR0001628280-26-045742
Jun 26, 202640001853327-26-000008
Jun 25, 20261440001950047-26-006485
Jun 23, 2026SCHEDULE 13D/A0001104659-26-076961
Jun 23, 20261440001104659-26-076969